VZL 2004, 73(4):130-141

Primary Hypertension Pathogenesis

Marián Sninčák, Štefan Kujaník
Oddelenie vnútorných ochorení s JIS a EJ, LVN Košice, Slovenská republika
Ústav fyziológie LF UPJŠ v Košiciach, Slovenská republika

Primárna hypertenzia je najčastejším chronickým ochorením v priemyslových krajinách. Patogenéza esenciálnej hypertenzie zostáva predbežne ešte nejasná. Pravdepodobne je to však multifaktoriálne ochorenie, dané rôznymi vplyvmi prostredia v interakcii s ešte nedeterminovanou genetickou predispozíciou. Určitá diagnóza je možná len po vylúčení sekundárnej príčiny.
Prítomnosť len malého percenta sekundárnych foriem hypertenzie v celkovej populácii chorých s hypertenziou nás oprávňuje hľadať organickú, hmatateľnú príčinu; podozrenie má korešpondovať so striktnou adherenciou k štandardným diagnostickým procedúram a liečebné dôsledky môžu vyplývať z očakávanej diagnózy.

Keywords: Primárna hypertenzia; Hemodynamika; Patogenéza

Primary hypertension is the most common chronic disease in industrialized countries. Primary hypertension pathogenesis still remains unclear. However, it is probably a "multifactorial" disease, influenced by various environmetal factors in interaction with a so far undetermined genetic predisposition. A particular diagnosis can only be made through the exclusion of a secondary cause.A small percentage of secondary forms of hypertension in the total population of patients with hypertension justifies us to search for an organically tangible cause of this disease. Any suspicion should correspond with the observance of a standard diagnostic procedure and the appropriate therapy should follow from the expected diagnosis.

Keywords: Primary hypertension; Haemodynamics; Pathogenesis

Received: April 4, 2003; Published: December 1, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sninčák, M., & Kujaník, Š. (2004). Primary Hypertension Pathogenesis. Vojenské Zdravotnické Listy, 73(4), 130-141
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. WILKING, SVB., et al. Determinants of isolated systolic hypertension. JAMA, 1988, vol. 260, p. 3451-3455. Go to original source...
    2. STIMPEL, M. Arterial hypertension. Berlin, New York, Walter de Gruyter, 1996. 356 p.
    3. BALAŽOVJECH, I. Artériová hypertenzia. Martin, Osveta, 1999. 384 s.
    4. JULIUS, S. Transition from high cardiac output to elevated vascular resistance in hypertension. Am. Heart J., 1988, vol. 116, p. 600-606. Go to original source... Go to PubMed...
    5. LUND-JOHANSEN, P. Twenty-year follow up of hemodynamics in essential hypertension durring rest and exercise. Hypertension, 1991, vol. 18 (suppl III), p. 54-61. Go to original source... Go to PubMed...
    6. FOLKOW, B. "Structural factor" in primary and secundary Hypertension. Hypertension, 1990, vol. 16, p. 89-101. Go to original source... Go to PubMed...
    7. HEAGERTY, AM., et al. Small artery Structure in Hypertension. Dual processes of remodeling and growth. J. Hypertension, 1993, vol. 21, p. 391-397. Go to original source... Go to PubMed...
    8. BENETOS, A., et al. Large artery stiffness in Hypertension. J. Hypertension, 1997, vol. 15 (suppl. 2), p. S 89-S 97. Go to original source... Go to PubMed...
    9. CAMPBELL, RWF. - FRANCIS, GS. International Handbook of Hypertension, Warwick Printing Company, 1997. 103 p.
    10. GANTEN, D. - SCHMIDT, S. - PAUL, M. Genetics of primary hypertension. J. Cardiovasc. Pharmacol., 1994, vol. 24 (suppl 3), p. S 45-S 50. Go to original source...
    11. HARRAP, S. Hypertension: genus versus environment. Lancet, 1994, vol. 344, p. 167-171. Go to original source... Go to PubMed...
    12. CAROLL, D., et al. Pressor reactions to psychological stress and prediction of future blood pressure: data from the Whitehall II study. Br. Med. J., 1995, vol. 310, p. 771-776. Go to original source... Go to PubMed...
    13. ELLIOTT, P. Observational studies of salt and blood pressure. Hypertension, 1991, vol. 17 (suppl I), p. 3-8. Go to original source...
    14. STIMPEL, M. - KAUFMANN, W. - WAMBACH, G. Atrial natriuretic peptide (ANP) in essential hypertension: humoral marker for salt sensitivity and hypertensive heart disease at a clinically asymptomatic state? (in German). Kardiol., 1988, vol. 77 (suppl 2), p. 92-98.
    15. GALETTI, F., et al. Evaluation of Protocol for the Assesment of Salt Sensitivity. Amer. J. Hypert., 1997, vol. 10, p. 462-466. Go to original source...
    16. WEIDMANN, P., et al. Potential causes of insulin resistance and possible effects of insulin resistance and/or hyperinsulinaemia on blood - pressure - regulating factors. J. Hypertens., 1995, vol. 13 (suppl. 2), p. S 65-S 72.
    17. MORRIS, AD. - PETRIE, JR. - CONNEL, JMC. Insulin and hypertension. J. Hypertens., 1994, vol. 12, p. 726-736. Go to original source...
    18. DAVIDSON, MB. Clinical implications of insulin resistance syndromes. Am. J. Med., 1995, vol. 99, p. 420-426. Go to original source... Go to PubMed...
    19. FERRANNINI, E., et al. Insulin resistance in essential hypertension. N. Engl. J. Med., 1987, vol. 317, p. 350-356. Go to original source... Go to PubMed...
    20. KAHN, CR. Causes of insulin resistance. Nature, 1995, vol. 373, p. 384-385. Go to original source... Go to PubMed...
    21. JULIUS, S. Current Trends in the Treatment of Hypertension. Amer. Hypert., 1997, vol. 10, p. 300 S-305 S. Go to original source...
    22. ROSOLOVÁ, H. Hypertenze a diabetes mellitus - patofyziologie a rizika. Vnitř. Lék., 1999, roč. 45, č. 11, s. 655-660.
    23. KANNEL, W., et al. Relation of adiposity to blood pressure and development of hypertension: The Framingham Study. Ann. Intern. Med., 1967, vol. 67, p. 48-59. Go to original source... Go to PubMed...
    24. STAMLER, J., et al. Findings of the international cooperative INTERSALT study. Hypertension, 1991, vol. 17, (suppl. I), p. 9-15. Go to original source...
    25. LANDESBERG, L. Diet, obesity and hypertension: An hypothesis involving insulin, the sympathetic nervous system, and adaptative thermogenesis. Q. J. Med., 1986, vol. 236, p. 1081-1090.
    26. MULWANY, MJ. Effect of Electrolyte Transport on the Response of Arteriolar Smooth Muscle. J. Cardiovasc. Pharmacol., 1998, vol. 6, p. 582-587.
    27. LAVIE, CJ. - VENTURA, HO. - MESSERLI, FH. Cardiac structural adaptation to obesity, primary hypertension, and combined obesity - hypertension. Postgraduate Med., 1992, vol. 91, p. 131-143. Go to original source... Go to PubMed...
    28. GOLDSTEIN, DS. Plasma catecholamines and essential hypertension. An analytical review. Hypertension, 1983, vol. 5, p. 86-99. Go to original source... Go to PubMed...
    29. BALAŽOVJECH, I. Katecholamíny pri arteriálnej hypertenzii. Folia Fac. Med., 1989, vol. 27, s. 9-200.
    30. SINGH, PP. Reduced Heart rate Variability and New Onset of Hypertension. Hypertension, 1998, vol. 32, p. 293-297. Go to original source... Go to PubMed...
    31. KRAHULEC, B. - ŠTRBOVÁ, L. - BALAŽOVJECH, I. Autonomic neuropathy and hypertension increase QT dispersion in diabetics. In Bacharová, L., McFarlane, PX. (eds). Electrocardiology, 1997, World Sci. Publ. Co., 1998, vol. 117, p. 117-120.
    32. JULIUS, S. Hyperkinetic Borderline Hypertension in Tecumseh Michigan. J. Hypertens., 1991, vol. 9, p. 77-84. Go to original source... Go to PubMed...
    33. SCHERWOOD, A. - HINDERLITER, AL. - LIGHT, KC. Psychosocial determinants of Hyperreactivity to stress in borderline hypertension. Hypertension, 1995, vol. 25, p. 384-390. Go to original source... Go to PubMed...
    34. MANCIA, G. The sympathetic nervous system in Hypertension. Hypertension, 1997, vol. 15, no. 12, p. 1553-1565. Go to original source... Go to PubMed...
    35. LARAGH, JH. The Renin System and four Lines of Hypertension Research. Hypertension, 1992, vol. 20, p. 267-279. Go to original source... Go to PubMed...
    36. GOODFRIED, TL. - ELLIOTT, ME. Angiotensin Receptors and their Antagonosis. Drug Ther., 1996, vol. 334, p. 1649-1654. Go to original source... Go to PubMed...
    37. TSUZUKI, S. Angiotensins II type 2 receptors inhibits Cell proliferation and activates tyrosine Phosphatase. Hypertension, 1996, vol. 28, p. 916-918. Go to original source... Go to PubMed...
    38. JANUSZEWICZ, A. The natriuretic peptides in hypertension. Curr. Opin. Cardiol., 1995, vol. 10, p. 495-500. Go to original source... Go to PubMed...
    39. WOOLFSON, RG. - POSTON, L. - De WARDENER, HE. Digoxin - like inhibitors of active sodium transport and blood pressure: the current status. Kidney Int., 1994, vol. 46, p. 297-309. Go to original source... Go to PubMed...
    40. BLAUSTEIN, MP. - HAMLIN, JM. Sodium transport Inhibition, Cell Calcium and Hypertension. Amer. J. Med., 1984, p. 45-49. Go to original source... Go to PubMed...
    41. LÜSCHER, TF. - SEO, B. - BÜHLER, F. Potential role of endothelin in hypertension. Controversy on endotelin in hypertension. Hypertension, 1993, vol. 21, p. 752-757. Go to original source... Go to PubMed...
    42. SCHIFFRIN, EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension, 1995, vol. 25, p. 1135-1145. Go to original source... Go to PubMed...
    43. HAYNES, WG., et al. Systemic endotelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation, 1996, vol. 93, p. 1860-1870. Go to original source... Go to PubMed...
    44. SCHIFFRIN, EL. Endotelin and endotelin antagonists in hypertension. J. Hypertens., 1998, vol. 16, p. 1891-1895. Go to original source... Go to PubMed...
    45. KRUM, H., et al. The effect of endotelin receptor antagonist, bosenthan, on blood pressure in patients with essential hypertension. New Engl. J. Med., 1998, vol. 338, no. 19, p. 784-790. Go to original source... Go to PubMed...
    46. LAZÚROVÁ, I. - KRAMER, HJ. Endotelíny - fyziológia, patofyziológia a význam pri artériovej hypertenzii. Vnitř. Lék., 2000, vol. 46, č. 10, s. 719-723.
    47. JERIE, P. Co je arteriální hypertenze? Bilance padesáti let výzkumu a racionální léčby. Čas. Lék. čes., 1998, roč. 137, č. 24, s. 739-742.

    Return to the content